Need an oil spill lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
A medication approved by the Food and Drug Administration (FDA) to treat migraine headaches is scheduled to become available in the United States this month. Cambia (diclofenac potassium for oral solution) was found to reduce migraine pain within 30 minutes, according to a study published in Cephalalgia, the international journal of headache.
A newly approved drug for the treatment of arthritis in patients at risk of developing NSAID-associated gastric ulcers has been linked to a rare but serious hypersensitivity disorder known as Stevens Johnson Syndrome (SJS).
The FDA recently approved safety labeling revisions for darunavir tablets, also known as Prezista, to warn of adverse reactions including skin rashes and Stevens Johnson Syndrome (SJS), according to MedScape.
A stimulant-type drug recently was added to the list of medications that may cause Stevens Johnson Syndrome (SJS), a rare but life-threatening condition affecting the skin and mucus membranes, causing the skin to blister and peel away in sheets. MedPage Today reported that drug maker Cephalon has agreed to update the drug’s label to warn of the potential risk of SJS and other serious rashes and hypersensitivity reactions.
Elizabeth Patton, 17, was a popular and athletic high school student in Brentwood, Tenn. She enjoyed playing basketball and helped lead her Ravenswood High School softball teammates to their first District 11-AAA regular season title last spring. But last week she met an untimely death by a most unexpected and rare autoimmune reaction to medication, according to News Channel 5.
![[ Beasley Allen Law Firm Logo ]](http://www.sjs-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}